Changes in adenosine triphosphate (ATP) and peroxynitrite (ONOO − ) concentrations have been correlated in a number of diseases including ischemia-reperfusion injury and drug-induced liver injury. Herein, we report the development of a fluorescent probe ATP-LW, which enables the simultaneous detection of ONOO − and ATP. ONOO − selectively oxidizes the boronate pinacol ester of ATP-LW to afford the fluorescent 4-hydroxy-1,8-naphthalimide product NA-OH (λ ex = 450 nm, λ em = 562 nm or λ ex = 488 nm, λ em = 568 nm). In contrast, the binding of ATP to ATP-LW induces the spirolactam ring opening of rhodamine to afford a highly emissive product (λ ex = 520 nm, λ em = 587 nm). Due to the differences in emission between the ONOO − and ATP products, ATP-LW allows ONOO − levels to be monitored in the green channel (λ ex = 488 nm, λ em = 500−575 nm) and ATP concentrations in the red channel (λ ex = 514 nm, λ em = 575−650 nm). The use of ATP-LW as a combined ONOO − and ATP probe was demonstrated using hepatocytes (HL-7702 cells) in cellular imaging experiments. Treatment of HL-7702 cells with oligomycin A (an inhibitor of ATP synthase) resulted in a reduction of signal intensity in the red channel and an increase in that of the green channel as expected for a reduction in ATP concentrations. Similar fluorescence changes were seen in the presence of SIN-1 (an exogenous ONOO − donor).
In this work, we set out to develop an endoplasmic reticulum (ER) directed ESIPT-based ONOO ratiometric fluorescent probe (ABAH-LW). ABAH-LW was synthesized in four steps and found to have a high sensitivity and selectivity towards the detection of ONOO. ABAH-LW was able to detect low concentrations of ONOO (limit of detection = 21.4 nM) within seconds producing a ratiometric change in fluorescence intensity. ABAH-LW further demonstrated the ability to ratiometrically image endogenous and exogenous ONOO in HeLa cells. Moreover, co-localization experiments were carried out using commercially available ER-Tracker Red, Lyso-Tracker Red and Mito-Tracker-Red, which were co-stained with ABAH-LW in HeLa cells. For ER-Tracker Red, Pearson's correlation co-efficient of 0.93 was determined and 3D surface plot analysis illustrated a large overlap between ABAH-LW and ER-Tracker Red using both red and blue channels. In addition some co-localisation with Mito-Tracker Red and ABAH-LW was observed (0.73).
The
transition metal-based layered double hydroxides (LDHs) have
been extensively studied as promising functional nanomaterials owing
to their excellent electrochemical activity and tunable chemical composition.
In this work, using acetate anions (Ac–) as intercalating
elements, the NiCo-LDH nanosheets arraying on Ni foam with different
amounts of Ac– anion intercalation or volume of
hydrothermal solution were prepared by a simple hydrothermal method.
The optimized amount of Ac– anions expanded the
interlayer space of LDH nanosheets from 0.8 to 0.94 nm. An ultrahigh
specific capacity of 1200 C g–1 at 1 A g–1 (690 C g–1 without Ac– anions),
an outstanding rate capability of 72.5% at 30 A g–1, and a cycle stability of 79.90% after 4500 cycles were mainly attributed
to the higher interlayer spacing of Ac– anion intercalation.
The enlarged interlayer spacing was beneficial for stabilizing the
α-phase of LDHs and accelerating the electron transport and
electrolyte penetration in the electrochemical reaction. This work
sheds light on the mechanisms of the interlayer spacing regulation
of NiCo-LDH nanosheets and offers a promising strategy to synthesize
functional nanomaterials with excellent electrochemical performance
via integrating their unique layered structure and interlayer anion
exchange characteristics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.